Ranking highlights Genpact's outstanding
global delivery and AI capabilities, including advanced digital and
AI solutions across regulatory and medical affairs value
chain
NEW
YORK, July 30, 2024 /PRNewswire/
-- Genpact (NYSE: G), a global professional services and
solutions firm delivering outcomes that shape the future, has been
recognized as a Leader in the Everest Group Life
Sciences Regulatory and Medical Affairs Operations PEAK
Matrix® assessment for 2024.
As stated in the Everest Group report, Genpact earned this
distinction due to its comprehensive suite of digital solutions,
strategic partnerships with companies such as AWS and Veeva, and
cutting-edge AI capabilities. Everest Group also highlighted
notable Genpact digital and AI solutions:
- Health Agency Q&A, which uses generative AI and
Natural Language Processing (NLP) to automate responses to health
authority inquiries, and
- Marketing Authorization Supply Transfer, which enables
integrated planning and tracking of regulatory and supply
milestones with built-in business algorithms and regulatory
intelligence.
"In today's complex global regulatory environment, enterprises
need partners to navigate regulations, drive AI innovation, and
achieve speed to market, safety, and compliance," said
Sanjiv Tandon, Global Business
Leader, Life Sciences, Genpact. "Being recognized as a
top-three leader in life sciences underscores our commitment to
delivering innovative AI solutions, supported by deep industry
expertise, to our clients worldwide."
The report also acknowledged Genpact's strong presence in the
medical technology space, highlighting Genpact's expertise in key
opinion leader engagement and medical science liaison support, both
of which ensure clients receive top-tier consultation and
operational support.
"Life sciences enterprises face challenges such as navigating
complex compliance systems, adapting to shifting regulations, and
meeting diverse regional standards," said Lloyd Fernandes, Life Sciences Practice
Director, Everest Group. "As a result, there is increasing
reliance on external service providers for deep expertise and
advanced technology. Genpact is well-positioned to meet these
needs, offering comprehensive services across regulatory affairs.
Its ability to integrate deep domain expertise with robust digital
solutions to automate regulatory tasks and enhance compliance
processes is highly regarded by clients."
Visit here for more information about Genpact's life science
solutions and services.
About Genpact
Genpact (NYSE: G) is a global
professional services and solutions firm delivering
outcomes that shape the future. Our 125,000+ people across 30+
countries are driven by our innate curiosity, entrepreneurial
agility, and desire to create lasting value for clients. Powered
by our purpose – the relentless pursuit of a world that works
better for people – we serve and transform leading
enterprises, including the Fortune Global 500, with our deep
business and industry knowledge, digital operations services,
and expertise in data, technology, and AI.
Get to know us at genpact.com and
on LinkedIn, X, YouTube,
and Facebook.
MEDIA CONTACT:
Sue
Martenson
Genpact Media
Relations
susan.martenson@genpact.com
+1 978.905.9582
View original content to download
multimedia:https://www.prnewswire.com/news-releases/genpact-recognized-as-a-leader-in-life-sciences-regulatory-and-medical-affairs-in-2024-everest-group-peak-matrix-assessment-302210115.html
SOURCE Genpact Ltd.